Progyny (PGNY) CEO buys 79,500 shares at $24.29 average

Progyny, Inc. (PGNY) disclosed that its Chief Executive Officer and director purchased 79,500 shares of common stock on 11/13/2025.

Rhea-AI Filing Summary

Progyny, Inc. (PGNY) disclosed that its Chief Executive Officer and director purchased 79,500 shares of common stock on 11/13/2025. The shares were bought at a weighted average price of $24.288 per share, in multiple trades at prices ranging from $23.73 to $24.52. Following this transaction, the reporting person beneficially owns 680,251 shares directly and an additional share indirectly through PECO ANEVSKI 2020 SD LLC. The filing notes that the purchase was made to offset a tax withholding obligation arising from the net settlement of performance stock units reported the same day.

Insider Trade Summary

Net Buyer: 79,500 shares

Net Buy 2 txns

Insider Anevski Peter

Role CHIEF EXECUTIVE OFFICER

Bought 79,500 shs ($1.93M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	79,500	$24.288	$1.93M
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 680,251 shares (Direct); Common Stock — 1 shares (Indirect, See footnote)

Footnotes (3)

1. F1. These shares were purchased to offset a tax withholding obligation arising from the net settlement of performance stock units as reported in a Form 4 filed by the Reporting Person on November 13, 2025.
2. F2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.73 to $24.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
3. F3. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Progyny (PGNY) report in this Form 4?

Progyny reported that its Chief Executive Officer and director purchased 79,500 shares of common stock on 11/13/2025 in an open-market transaction.

At what price did the Progyny CEO buy the 79,500 PGNY shares?

The CEO bought 79,500 shares at a weighted average price of $24.288 per share, with individual trades executed between $23.73 and $24.52.

How many Progyny (PGNY) shares does the reporting person own after this transaction?

After the reported purchase, the reporting person beneficially owns 680,251 shares of Progyny common stock directly, plus an additional share held indirectly through PECO ANEVSKI 2020 SD LLC.

Why did the Progyny CEO purchase these PGNY shares?

The filing states the 79,500 shares were purchased to offset a tax withholding obligation arising from the net settlement of performance stock units reported on November 13, 2025.

What is noted about the price range of the PGNY insider share purchases?

The filing explains that the price in the form is a weighted average, and that the 79,500 shares were bought in multiple transactions at prices between $23.73 and $24.52, inclusive.

How are some of the Progyny shares held by the reporting person structured?

The filing notes that the reportable securities are held directly by the reporting person, with one share held indirectly through the PECO ANEVSKI 2020 SD LLC entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 08:22 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Anevski Peter

(Last) (First) (Middle)

C/O PROGYNY, INC.

1359 BROADWAY, 2ND FLOOR

(Street)

NEW YORK NY 10018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		P		79,500(1)	A	$24.288(2)	680,251	D
Common Stock								1	I	See footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were purchased to offset a tax withholding obligation arising from the net settlement of performance stock units as reported in a Form 4 filed by the Reporting Person on November 13, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.73 to $24.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

3. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Remarks:

	/s/ Mark Livingston, Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.